Skip to main content
Andrew Kraft, MD, Oncology, Tucson, AZ, Banner - University Medical Center Tucson

AndrewSKraftMD

Oncology Tucson, AZ

Director of the University of Arizona Cancer Center Sydney E. Salmon Endowed Chair Associate Vice President for Oncology Programs for the University of Arizona Health Sciences Professor of Medicine in the Department of Medicine, Division of Hematology/Onc

Dr. Kraft is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kraft's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1975 - 1978
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1975

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1996 - 2025
  • AZ State Medical License
    AZ State Medical License 2014 - 2022
  • SC State Medical License
    SC State Medical License 2004 - 2015
  • AL State Medical License
    AL State Medical License Active through 1996
  • MD State Medical License
    MD State Medical License 1978 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 1993

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Shop Talk
    Shop TalkJuly 20th, 2019
  • Shop Talk
    Shop TalkDecember 10th, 2016
  • Dr. William Cance Hired to Lead University of Arizona Cancer Center in Phoenix
    Dr. William Cance Hired to Lead University of Arizona Cancer Center in PhoenixNovember 6th, 2016

Grant Support

  • Senior LeadershipNational Cancer Institute2009–2012
  • Program Planning And EvaluationNational Cancer Institute2009–2012
  • Medical University Of South Carolina - Cancer Center Support GrantNational Cancer Institute2009–2012
  • Developmental FundsNational Cancer Institute2009–2012
  • Novel Inhibitors Of PIM Protein KinasesNational Cancer Institute2009
  • Mechanisms By Which Proteasome Enhance ApoptosisNational Cancer Institute2004–2007
  • Hollings Cancer Center Planning GrantNational Cancer Institute2003–2005
  • Mechanisms By Which Proteasome Enhance ApoptosisNational Cancer Institute2004
  • PIM 1 Protein Kinase As A Target For Drug DiscoveryNational Cancer Institute2003
  • PIM 1 Protein Kinase As A Target For Drug DiscoveryNational Cancer Institute2002–2003
  • Training In Pharmacology Of Antineoplastic AgentsNational Cancer Institute1999–2003
  • Control Of Differentiation Of Human PromyelocytesNational Cancer Institute1999–2003
  • Developmental Therapeutics ProgramsNational Cancer Institute2001–2002
  • Phase II Trial Of Bryostatin 1 For Treatment Of Stage IV Breast CancerNational Center For Research Resources1999–2002
  • Regulation Of Prostate Cancer Programmed Cell DeathNational Cancer Institute1998–2001
  • Phase I/II RX Of Chronic Myelogenous Leukemia With Bryostatin 1National Center For Research Resources1998–2000
  • Bryostatin 1 Treatment For Patients With Metastatic Malignant MelanomaNational Center For Research Resources1998–2000
  • Mechanism Of Action Of GM-CSFNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
  • Control Of Differentiation Of PromyelocytesNational Cancer Institute1996–1998
  • Bryostatin1 In Chronic Myelogenous LeukemiaNational Center For Research Resources1997
  • Bryostatin 1 In Metastatic Malignant MelanomaNational Center For Research Resources1996–1997
  • Differentiation Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute1996
  • Bryostatin 1 Therapy Of Metastatic MelanomaNational Cancer Institute1996
  • Differentiation Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute1995–1996
  • Control Of Differentiation Of PromyelocytesNational Cancer Institute1994–1996
  • Bryostatin 1 Therapy Of Metastatic MelanomaNational Cancer Institute1995
  • Mechanism Of Action Of GM-CSFNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1995
  • Control Of Differentiation Of Human PromyelocytesNational Cancer Institute1986–1993
  • The Role Of Protein Kinase C In Mediating N-RAS ProteinFogarty International Center1989

Hospital Affiliations